MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT
Zhan Zhang(Third Affiliated Hospital of Zhengzhou University), Carla Grandori(Precision for Medicine (United States)), Janell M. Schelter, Ryan Walsh(Texas Neurology), Julja Burchard(Rosetta Stone (United States)), Joseph R. Marszalek(The University of Texas MD Anderson Cancer Center), Maki Imakura, Steven R. Bartz(Rosetta Stone (United States)), Peter S. Linsley(Rosetta Stone (United States)), Aaron N. Chang(Baylor University Medical Center), Hongyue Dai(Rosetta Stone (United States)), Michele A. Cleary(The Kids Research Institute Australia), Michael Carleton(Matrix Research (United States)), Xudong Dai, Robert L. Diaz, Hong Sun
Cited by 284
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
CTLA-4 is a second receptor for the B cell activation antigen B7.
|The Journal of Experimental Medicine|1991|1.7k
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
|Annual Review of Cell and Developmental Biology|2000|1.3k
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
|Cancer Discovery|2017|964
Direct activation of TERT transcription by c-MYC
|Nature Genetics|1999|903